Support
Support
Search

News & Events

Keep up to date with the latest news and events from iRhythm including press releases, conferences, interviews, and more.

Investor news

News

News
Published on November 21, 2022
Behind the Bell interview with Quentin Blackford
iRhythm President and CEO discusses iRhythm’s patient-first mission to impact people across the globe.
Read more
News
Published on November 18, 2022
Results of Four Studies Demonstrating Clinical, Economic Value of iRhythm’s Product Portfolio Presented at American Heart Association ’22
Clinical studies presented at the American Heart Association 2022 Scientific Sessions event demonstrate compelling diagnostic and health economic value
Read more
News
Published on November 16, 2022
New Research Confirms that Zio® by iRhythm Provides High Value From a Health Economic Perspective
A new analysis of iRhythm’s mSToPS trial reveals that Zio® XT provided high value from a health economic perspective
Read more
News
Published on July 22, 2022
iRhythm Gains FDA Clearance for its Clinically Integrated ZEUS System
iRhythm Technologies, Inc., a leading digital healthcare solutions company focused on the advancement of cardiac care, today announced it received FDA 510(k) clearance for its ZEUS (Zio ECG Utilization Software) System for the Zio Watch.
Read more
News
Published on April 04, 2022
Zio® by iRhythm Shown to Prevent Hospital Admissions, Aid in Early Detection of AF
iRhythm Technologies, Inc. announces the results of three clinical research studies presented at The American College of Cardiology’s 71st Annual Scientific Session & Expo (ACC 22)
Read more
News
Published on March 18, 2022
Zio® by iRhythm Shows Significantly Higher Documentation of Atrial Fibrillation and Atrial Flutter Compared to Holter Monitors, Event Monitors
iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, announced that the results of the KP-Rhythm2 study, titled “Diagnostic yield, outcomes and resource utilization with different ambulatory electrocardiographic monitoring strategies,” were published in the American Journal of Cardiology (AJC).
Read more
News
Published on October 05, 2021
mSToPS Clinical Trial Demonstrates Zio by iRhythm Significantly Improves Health Outcomes for Specific Patient Populations
Data from the mHealth Screening to Prevent Strokes study published in PLOS One shows continuous monitoring leads to earlier diagnosis and prevents adverse cardiac events, furthering the case for cardiac screening.
Read more
News
Published on July 08, 2021
iRhythm® Technologies and the National Association of Managed Care Physicians Partner to Study the Value of Ambulatory Cardiac Monitoring Solutions
iRhythm Technologies, Inc. and the Value Based Care Council (VBCC) of the National Association of Managed Care Physicians (NAMCP) today announced a one-of-a-kind partnership to help payers and managed care organizations (MCOs) effectively assess the value of long-term continuous cardiac monitoring.
Read more
News
Published on May 24, 2021
iRhythm® Technologies Continues to Fuel Innovation in Cardiac Monitoring and Unveils Two FDA Clearances for Superior Patient Care
iRhythm Technologies, Inc. announced two new 510(k) clearances – one for a new and improved design of its flagship monitor and a second for updated artificial intelligence (AI) capabilities.
Read more
News
Published on April 09, 2020
iRhythm Technologies Announces Update on COVID-19 Impact and Response
iRhythm Technologies provided an update on the impact the company is experiencing due to the COVID-19 pandemic and the steps the company is taking in response.
Read more
News
Published on November 06, 2019
iRhythm Technologies Announces Third Quarter 2019 Financial Results
iRhythm Technologies Announces Third Quarter 2019 Financial Results
Read more
News
Published on October 22, 2019
iRhythm Technologies to Report Third Quarter Financial Results on November 5, 2019
iRhythm Technologies, Inc. announced that it will release financial results for the third quarter.
Read more
News
Published on September 10, 2019
iRhythm Technologies Announces Closing of Follow-on Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
iRhythm Technologies, Inc. announced the closing of its underwritten public offering of 1,575,342 shares of its common stock at a public offering price of $73.00 per share.
Read more
News
Published on September 05, 2019
iRhythm Technologies Announces Pricing of Public Offering of Common Stock
iRhythm Technologies, Inc. announces pricing of public offering for common stock.
Read more
News
Published on September 04, 2019
iRhythm Announces Collaboration with Verily to Develop Health Management Solutions for Atrial Fibrillation Patients
iRhythm Announces Collaboration with Verily to Develop Health Management Solutions for Atrial Fibrillation Patients
Read more
News
Published on August 27, 2019
iRhythm Technologies to Present at the 17th Annual Morgan Stanley Global Healthcare Conference
iRhythm Technologies, Inc. announced the company will be participating in the upcoming 17th Annual Morgan Stanley Global Healthcare Conference in New York, NY.
Read more
News
Published on July 31, 2019
iRhythm Technologies Announces Second Quarter 2019 Financial Results
iRhythm is a leading digital health care company redefining the way cardiac arrhythmias are clinically diagnosed.
Read more
News
Published on July 24, 2019
iRhythm Technologies to Present at the 39th Annual Canaccord Genuity Global Growth Conference
iRhythm Technologies, Inc. announced the company will be participating in the upcoming 39th Annual Canaccord Genuity Global Growth Conference in Boston, MA.
Read more
News
Published on July 17, 2019
iRhythm Technologies to Report Second Quarter Financial Results on July 31, 2019
iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today announced that it will release financial results for the second quarter 2019 after the close of trading on Wednesday, July 31, 2019.
Read more
News
Published on June 05, 2019
iRhythm Technologies to Present at the BMO Capital Markets 2019 Prescriptions for Success Healthcare Conference
Today, iRhythm Technologies, Inc. (NASDAQ: IRTC) announced the company will be participating in the upcoming BMO Capital Markets 2019 Prescriptions for Success Healthcare Conference in New York, NY.
Read more
News
Published on May 07, 2019
iRhythm Technologies Announces First Quarter 2019 Financial Results, Raises Guidance for Full Year 2019
iRhythm Technologies Announces First Quarter 2019 Financial Results, Raises Guidance for Full Year 2019.
Read more
News
Published on April 23, 2019
iRhythm Technologies to Report First Quarter Financial Results on May 7, 2019
iRhythm Technologies to Report First Quarter Financial Results on May 7, 2019
Read more
News
Published on December 21, 2017
iRhythm Technologies to Present at the 38th Annual J.P. Morgan Healthcare Conference
iRhythm Technologies to Present at the 38th Annual J.P. Morgan Healthcare Conference
Read more
of 0

Investor presentations

HIMSS25 - March 3-6 - Las Vegas, NV

HIMSS Global Health Conference & Exhibition

Join us at booth 5346 at HIMSS in Las Vegas, NV March 3-6

ACC 25 - March 29-31 - Chicago, IL

American College of Cardiology

Join us at booth 8053 at the American College of Cardiology annual meeting in Chicago, IL, March 29-31.

ACP25 - April 3-5 - New Orleans, LA

American College of Physicians Internal Medicine Meeting

Join us in the Tech Hub booth 2113 at the American College of Physicians annual meeting in New Orleans, LA April 3-5 

WEB0085.01

Contact us